is trulicity a glp-1 receptor agonists – Peripheral Brain Current Insights, Advantages and Challenges

This is largely attributed to glucagon suppression and slow gastric emptying

Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030

sleep apnea and other sleep disorders

In people with T2DM, exenatide treatment reduced serum levels of inflammatory proteins linked to AD risk (88), and studies with liraglutide or sitagliptin (a DPP-IV inhibitor that elevates GLP-1 levels) reported lower cytokine levels and modest cognitive improvements (89)

S., El-Demerdash, E., & El-Mesallamy, H